The All-In-One Guru Screener can be used to find insider buys over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$1,000,000+” and duration to "August 2015."
According to the above filters, the following are the recent buys from company insiders over the past week.
On Aug. 19, Stone House Capital Management, which now holds more than 10% of A M Castle & Co (CAS), bought 500,000 shares at an average price of $3.26 and a total cost of $1,630,000. Since that buy, the price of the stock has tanked by 19.90%.
The company has an insider ownership of 7% and an institutional ownership of 83%.
The price of A M Castle has dropped by 74% during the last 12 months, and is trading with a very low P/B ratio of 0.89 and a forward P/E of 10.99. The company has negative returns with ROA -21.03% and ROE -80.37%. Financial strength is rated 6/10 and the company doesn’t have enough cash to pay its debt, as cash to debt is 0.04.
The main shareholder holding the company is Chuck Royce (Trades, Portfolio) who holds 7.45% of outstanding shares, followed by Arnold Schneider (Trades, Portfolio) with 0.59%.
On Aug. 19, Medifirst Solutions Inc. (MFST) CEO and Director Bruce Schoengood bought 3,020,000 shares at an average price of $0.01 and a total cost of $30,200. Since that buy, the price of the stock has increased a whopping 100%.
On Aug. 20 and 25, SOFTBANK Group Corp continued to buy shares of Sprint Corp (S) as reported in previous articles (1, 2). This week it bought a total of 35,998,602 shares and a total cost of $170,220,800. Since that buy, the stock has risen again by 6.3% and 7.9% respectively.
On Aug. 20, Opko Health Inc. (OPK) CEO and Chairman Phillip Frost bought 544,000 shares at an average price of $12.32 and a total cost of $6,702,080. Since that buy, the price of the stock has decreased by 9.7%.
The company has an insider ownership of 8% and an institutional ownership of 96%.
The price of OPK has risen by 28% during the last 12 months and is trading with a forward P/E of 1111.11. The company has negative returns, with ROA of -18.87% and return on equity -30.36%. The returns are having the best performance in the company’s history.
The main shareholder of the company is Jim Simons (Trades, Portfolio) who holds 0.42% of outstanding shares, followed by George Soros (Trades, Portfolio) with an easy stake of 0.05%.
On Aug. 21 and 26, JAB Cosmetics B.V., which now holds more than 10% outstanding shares of Coty Inc. (COTY), bought a total of 1,067,100 shares at the prices of $28.84 and $28.06, respectively.
The company has an insider ownership of 2% and an institutional ownership of 24%.
The price of Coty has risen by 68% during the last 12 months and is trading with a P/E of 44.74. The company has positive returns, with ROA of 3.69% and return on equity of 31.91 that is outperforming the 91% of its competitors.
The main shareholder of the company is Jim Simons (Trades, Portfolio) who holds 0.52% of outstanding shares, followed by Diamond Hill Capital (Trades, Portfolio) with 0.14%.
On Aug. 21 and Aug. 24, Coliseum Capital Management bought a total of 1,422,410 shares in BioScrip Inc (BIOS) for a total of $2,629,830. The insider bought shares of the company in two stakes at the prices of $1.81 and $1.88.
The company has an insider ownership of 3% and an institutional ownership of 97%.
The price of BioScrip has tanked by 72% during the last 12 months, but is still trading with very high ratios, such as forward P/E of 117.65. The company has very negative returns with ROE of -191.72% and ROA of -45.97%.
The main shareholder is Diamond Hill Capital (Trades, Portfolio) which holds 3.82% of outstanding shares, followed by Mario Gabelli (Trades, Portfolio) with 1.65%.
On Aug. 24, two insiders purchased a total of 2,820,346 shares of BreedIt Corp (BRDT) and these transactions have had a total cost of $28,204. Since that buy, the price of the stock doubled from $0.01 to $0.02.
On Aug. 25, Glenview Capital Management,which holds more than 10% of outstanding shares of Tenet Healthcare Corp (THC), bought 500,000 shares at the average price of $48.39, amounting to a total cost of $24,195,000. Since that buy, the price of the stock has increased by 2.70%.
The company has an insider ownership of 3% and an institutional ownership of 99%.
The price of Tenet has dropped by 19% during the last 12 months, and is trading with a very high P/E ratio of 96.80. The company has easy returns, with ROE of 7.46% and ROA of 0.30%. Financial strength is rated 6/10 but the company’s cash to debt ratio is very low at 0.02 and is ranked lower than 93% of its competitors.
The main shareholder of the company is Larry Robbins (Trades, Portfolio) who holds 14.86% of outstanding shares, followed by Vanguard Health Care Fund (Trades, Portfolio) with 1.41%.
On Aug. 25, Redmile Group LLC, which holds more than 10% of outstanding shares of Array BioPharma Inc. (ARRY), bought 790,000 shares at the average price of $5.38, paying a total of $4,250,200. Since that buy, the price of the stock has increased by 8.6%.
The company has an insider ownership of 2% and an institutional ownership of 90%.
The price of Array BioPharma has risen by 49% during the last 12 months, and is trading with a very high P/E ratio of 587. The company has a very high return on equity of 300% and a low return on assets of 5.56%. Financial strength is rated 5/10 and the company’s cash to debt ratio is positive but still underperforming 73% of its competitors.
The only shareholder of the company is Jim Simons (Trades, Portfolio), who holds 0.57% of outstanding shares.
On Aug. 26, Director Wayne B. Hughes of American Homes 4 Rent (AMH) bought 4,000,000 shares at the average price of $15.53, paying a total of $62,120,000. Since that buy, the price of the stock has increased by 2.4%.
The company has an institutional ownership of 92%.
The price of American Homes 4 Rent has dropped by 10% during the last 12 months, and is trading with a very low P/B ratio of 1.01. The company has negative returns with ROA of -0.90% and ROE of -2.28%. Financial strength is rated 5/10 and the company’s cash to debt ratio is outperforming 84% of its competitors.
The main shareholder of the company is Chris Davis (Trades, Portfolio) with 0.27% of outstanding shares, followed by Jim Simons (Trades, Portfolio) with 0.24%.
